Molecular aspects of neurodegeneration in Alzheimer's disease

Functional Neurology

Volumn 17, Issue 2, 2002, Pages 65-70

  Russo, Claudio ^a   Venezia, Valentina ^a   Salis, Serena ^a   Dolcini, Virginia ^a   Schettini, Gennaro ^a  

^a ADVANCED BIOTECHNOLOGY CENTER   (Italy)

Author keywords

Alzheimer's disease; Amyloid beta peptides; Amyloid precursor protein

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; PRESENILIN 1; PRESENILIN 2; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; PROTEINASE; SECRETASE;

ALZHEIMER DISEASE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; DEMENTIA; FAMILIAL INCIDENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NERVE CELL NETWORK; NERVE DEGENERATION; NEUROPATHOLOGY; POINT MUTATION; PREVALENCE; PROTEIN PROCESSING; REVIEW; BRAIN; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; ENDOPEPTIDASES; HUMAN; NERVE DEGENERATION; SUPPORT, NON-U.S. GOV'T; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; HUMANS;

EID: 0035995230     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Alzheimer's disease: Genes, proteins and therapy
2. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease
3. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
4. Tau protein pathology in neurodegenerative diseases
5. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
6. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
7. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein
8. Targeting of cell-surface β-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments
9. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
10. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: Evidence for AbetaP channel-mediated cellular toxicity
11. Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
12. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
13. The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implication for the pathogenesis of Alzheimer's disease
14. The toxicity of the Alzheimer's β-amyloid peptide correlates with a distinct fiber morphology
15. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation
16. Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715 → Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease
17. Familial Alzheimer's disease: Genetic influences on the disease process
18. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
19. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
20. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi
21. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
22. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1
23. Alzheimer's disease. Tangle disentanglement
24. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
25. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta42 fibrils
26. Amyloid beta interacts with the amyloid precursor protein: A potential toxic mechanism in Alzheimer's disease
27. Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid
28. Presence of soluble amyloid β peptide precedes amyloid plaque formation in Down's syndrome
29. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease
30. Isoform-specific binding of apolipoprotein E to β-amyloid
31. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
32. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: Role of the intracellular adapter protein Fe65
33. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides
34. Dominant and differential deposition of distinct beta-amyloid peptide species, AbetaN3(pE), in senile plaques
35. Heterogeneity of water-soluble amyloid β-peptide in Alzheimer's disease and Down's syndrome brains
36. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain
37. Presenilin-1 mutations in Alzheimer's disease
38. Alzheimer's disease: Molecular consequences of presenilin-1 mutation
39. The Aβ 3-pyroglutamyl peptides found in senile plaque have greater β-sheet forming and aggregation propensities in vitro than full-length Aβ
40. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain
41. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation
42. The discrepancy between presenilin subcellular localization and {gamma}-secretase processing of amyloid precursor protein
43. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing
44. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
45. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins
46. The β-amyloid precursor protein APP is tyrosine phosphorylated in cells expressing a constitutively active form of the Abl protoncogene
47. Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation
48. Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid
49. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement
50. The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion